Literature DB >> 12460713

Skin constructs for replacement of skin tissues for in vitro testing.

Maria Ponec1.   

Abstract

Reconstructed human skin equivalents as an alternative to animal experimentation offer not only a way to concede to demands of regulatory authorities, animal welfare organizations, consumers and scientists, but also provide a means to improve and extend our knowledge on biological processes in the skin. Presently, various skin reconstructs are available composed either of the epidermal compartment only or of both the epidermal and dermal compartments. Within each compartment various types of cells can be incorporated, including keratinocytes, melanocytes and Langerhans cells in the epidermal, and fibroblasts and endothelial cells in the dermal compartment. The quality of the human skin equivalents has now reached a point that their suitability for skin toxicity testing will make great progress. Next to the field of toxicity and safety standards, skin equivalents offer a well-characterized model for studies of the basic skin biology, wound repair, regulation of melanogenesis, pathogenesis of skin diseases and skin cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460713     DOI: 10.1016/s0169-409x(02)00112-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  15 in total

Review 1.  Tissue-engineered skin substitutes: an overview.

Authors:  Enrico Catalano; Andrea Cochis; Elena Varoni; Lia Rimondini; Barbara Azzimonti
Journal:  J Artif Organs       Date:  2013-10-05       Impact factor: 1.731

2.  Characterization of a human skin equivalent model to study the effects of ultraviolet B radiation on keratinocytes.

Authors:  Tara L Fernandez; Derek R Van Lonkhuyzen; Rebecca A Dawson; Michael G Kimlin; Zee Upton
Journal:  Tissue Eng Part C Methods       Date:  2014-06-03       Impact factor: 3.056

3.  Bryostatin and its synthetic analog, picolog rescue dermal fibroblasts from prolonged stress and contribute to survival and rejuvenation of human skin equivalents.

Authors:  Tapan K Khan; Paul A Wender; Daniel L Alkon
Journal:  J Cell Physiol       Date:  2017-07-11       Impact factor: 6.384

4.  Current advances in skin-on-a-chip models for drug testing.

Authors:  Qiang Zhang; Linda Sito; Mao Mao; Jiankang He; Yu Shrike Zhang; Xin Zhao
Journal:  Microphysiol Syst       Date:  2018-08-30

5.  Development of an in vitro model for radiation-induced effects on oral keratinocytes.

Authors:  T Tobita; K Izumi; S E Feinberg
Journal:  Int J Oral Maxillofac Surg       Date:  2010-01-15       Impact factor: 2.789

6.  Filaggrin deficiency leads to impaired lipid profile and altered acidification pathways in a 3D skin construct.

Authors:  Kateřina Vávrová; Dominika Henkes; Kay Strüver; Michaela Sochorová; Barbora Školová; Madeleine Y Witting; Wolfgang Friess; Stephan Schreml; Robert J Meier; Monika Schäfer-Korting; Joachim W Fluhr; Sarah Küchler
Journal:  J Invest Dermatol       Date:  2013-09-23       Impact factor: 8.551

7.  Artificial skin in perspective: concepts and applications.

Authors:  Carla A Brohem; Laura B da Silva Cardeal; Manoela Tiago; María S Soengas; Silvia B de Moraes Barros; Silvya S Maria-Engler
Journal:  Pigment Cell Melanoma Res       Date:  2010-11-09       Impact factor: 4.693

Review 8.  Microphysiological modeling of the reproductive tract: a fertile endeavor.

Authors:  Sharon L Eddie; J Julie Kim; Teresa K Woodruff; Joanna E Burdette
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-15

9.  Kinetic analysis on the skin disposition of cytotoxicity as an index of skin irritation produced by cetylpyridinium chloride: comparison of in vitro data using a three-dimensional cultured human skin model with in vivo results in hairless mice.

Authors:  Satoshi Kano; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2006-02-02       Impact factor: 4.200

10.  Generation of a Full-Thickness Human Skin Equivalent on an Immunodeficient Mouse.

Authors:  Nicole Diette; Igor Kogut; Ganna Bilousova
Journal:  Methods Mol Biol       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.